Skip to main content
OpenTrials
Recruiting

NCT Number: NCT06869512

Cooperative Extension and Cancer Survivorship

The goal of this clinical trial is to learn if a cancer survivor program, delivered via Cooperative Extension, is feasible and if it can improve health outcomes in cancer survivors who are post-active treatment.

Aim 1: Evaluate the feasibility and acceptability of SUCCESS. Hypothesis 1: SUCCESS will be feasible and acceptable as evidenced by delivery of the intervention among Educators (implementation), including in agreement with the curriculum in Phase 1 (fidelity) with >85% attendance (demand) among participants with >80% rating the intervention as acceptable or highly acceptable on 5-point Likert-type scale (acceptability).

Aim 2: Determine the preliminary efficacy of SUCCESS for improving HRQOL (primary outcome) and other psychosocial and health-related endpoints (e.g., financial toxicity) (secondary outcomes). Hypothesis 2: Compared to matched controls, adults LWBC who complete SUCCESS will have significant improvements in HRQOL per the PROMIS Global Health v1.2 at follow-up (i.e., after 6 weeks).

Aim 3: Examine changes in conserved transcriptional response to adversity (CTRA) gene expression in a subset of interventions participants at follow-up. Hypothesis 3: Adults LWBC who complete SUCCESS will experience significant CTRA down-regulation.

This is a single arm trial and there is no comparison group.

Participants will be asked to do survey- and Zoom-based data collection before and after completing the 6-week program.

Recruiting

Interested in participating?

Request Info

Key information

Conditions

Age range

18 year and older

Sex eligibility

All sexes

Study type

Interventional

Phase

Not applicable

Primary location

University of Oklahoma

Tulsa, Oklahoma, 74135, United States

Location status: Recruiting

Location contact

Ashlea C Braun, PhD

CONTACT

[email protected]

567-240-1582

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Previous adult-diagnosed cancer
  • Post active cancer treatment
  • No current active treatment, hormonal therapy permitted
  • Ability to get to group sessions
  • In Oklahoma

Exclusion criteria

  • Current palliative or hospice care
  • Surgical or medical history that precludes participation
  • Positive screen on the Physical Activity Readiness Questionnaire+ (PAR-Q+) without a doctor's note approving study participation

Treatment and study plan

SuCCESs

Behavioral

6 group-based sessions with 25 minutes of didactic content, 25 minutes of facilitated support group, and 10 minutes of group physical activity

Primary outcomes

  1. Delivery of sessions

    Time frame: Once per week for six weeks

    We will measure the percent of SUCCESS sessions delivered as planned by Educators

  2. Fidelity to SUCCESS protocol

    Time frame: Once per week for six weeks

    We will measure what percentage of planned SUCCESS content is delivered as instructed.

  3. Participant attendance

    Time frame: Once per week for six weeks

    We will measure how many enrolled participants attend each SUCCESS session

  4. Acceptability of SUCCESS

    Time frame: Measured after SUCCESS (week 7-8 of the clinical trial)

    We will administer a feasibility survey after SUCCESS for participants to rate how much they liked it. Rating will be on a 5-point Likert Scale ("How would you rate this program?" 1=poor, 5=excellent)

Secondary outcomes

  1. Diet quality

    Time frame: Baseline (week 1) and post-SUCCESS (week 7-8)

    We will measure diet quality as assessed via the National Cancer Institute Dietary Screener Questionnaire (DSQ). Outputs from the DSQ are intake of fruits and vegetables (cup equivalents), dairy (cup equivalents), added sugars (teaspoon equivalents), whole grains (ounce equivalents), fiber (g), and calcium (mg).

  2. Physical function

    Time frame: Baseline (week 1) and post-SUCCESS (week 7-8)

    We will measure physical function using the 30-second Timed Chair Rise (30sTCR), measured in seconds.

  3. Depressive symptoms

    Time frame: Baseline (week 1) and post-SUCCESS (week 7-8)

    Depressive symptoms will be measured using the Patient Health Questionnaire (PHQ-9). This provides a numeric score from 0-27, with higher=more depression

  4. Anxiety symptoms

    Time frame: Baseline (week 1) and post-SUCCESS (week 7-8)

    Anxiety symptoms will be measured using the General Anxiety Disorder-7 (GAD-7). This provides a numeric score from 0-21, with higher=more anxiety.

  5. Loneliness

    Time frame: Baseline (week 1) and post-SUCCESS (week 7-8)

    Loneliness will be measuring using the UCLA Loneliness Scale. This provides a numeric score from 20-80, with higher=more loneliness.

  6. Social isolation

    Time frame: Baseline (week 1) and post-SUCCESS (week 7-8)

    Social isolation will be measured using the PROMIS Social Isolation Short Form (SF). This provides a numeric score from 4-20, with higher scores indicating more social isolation.

  7. Financial Toxicity

    Time frame: Baseline (week 1) and post-SUCCESS (week 7-8)

    Financial toxicity will be measured using the COST: A FACIT Measure of Financial Toxicity (FACIT-COST). The FACT-COST provides a numeric score from 0-44, with higher meaning better financial well-being.

  8. Health-related quality of life

    Time frame: Baseline (week 1) and post-SUCCESS (week 7-8)

    Health-related quality of life (HRQOL) will be measured using the PROMIS Global Health v1.2, which yields Global Physical Health and Global Mental Health Scores, both of which range numerically from 4-20; higher indicates better HRQOL.

  9. Food insecurity

    Time frame: Baseline (week 1) and post-SUCCESS (week 7-8)

    Food insecurity will be measured using the USDA 6-item food insecurity screener. This yields a numeric score from 0-6, with higher=more food insecurity,

  10. Basic psychological needs

    Time frame: Baseline (week 1) and post-SUCCESS (week 7-8)

    Basic psychological needs according to Self-Determination Theory (autonomy, competence, relatedness) will be measured using the Basic Psychological Need Satisfaction Scale. This provides three scores (one per psychological need) that ranges from 1-7, with higher=more of that need met.

  11. Self-reported pain

    Time frame: Baseline (week 1) and post-SUCCESS (week 7-8)

    Pain will be measured using the Pain, Enjoyment, and General Activity (PEG) scale which provides a numeric score from 0-10, with 10=more pain and more interference from pain.

  12. Conserved Transcriptional Response to Adversity (CTRA) gene expression

    Time frame: Baseline (week 1) and post-SUCCESS (week 7-8)

    Remote blood sampling procedures will be used to collect blood spots. RNA will be extracted from spots and sequenced for quantification of the 53-gene contrast score that comprises CTRA. This will only be done in a subset of participants.

  13. Physical function

    Time frame: Baseline (week 1) and post-SUCCESS (week 7-8)

    We will measure physical function using 5 Times Sit-to-Stand (5xSTS) tests, measured in seconds.

  14. Financial Toxicity

    Time frame: Baseline (week 1) and post-SUCCESS (week 7-8)

    Financial toxicity will be measured using the Composite Financial Burden Score (CFBS). The CFBS provides a numeric score from 0-6; higher scores denote increased financial burden.

Study contacts

Contact information is provided by the study sponsor or research team.

Ashlea C Braun, PhD

CONTACT

[email protected]

15672401582

Sponsors and collaborators

Lead sponsor

University of Oklahoma

Other

Collaborators

  • Oklahoma State University

Registry information

Official study title

Cooperative Extension and Cancer Survivorship: Supportive Care Via Cooperative Extension Services (SUCCESS)

Acronym: SUCCESS

Important dates

Study start
2025
Primary completion
2026
Study completion
2026
First posted
Mar 11, 2025
Registry last updated
Jun 26, 2025

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.